Marconi, A, Di Forti, M, Lewis, CM, Murray, RM, Vassos, E.
Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull
2016; 42: 1262–9.
Henquet, C, Murray, R, Linszen, D, van Os, J.
The environment and schizophrenia: the role of cannabis use. Schizophr Bull
2005; 31: 608–12.
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, et al.
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet
2007; 28: 319–28.
Semple, DM, McIntosh, AM, Lawrie, SM.
Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol
2005; 19: 187–94.
Large, M, Sharma, S, Compton, MT, Slade, T, Nielssen, O.
Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry
2011; 68: 555–61.
Myles, N, Newall, H, Nielssen, O, Large, M.
The association between cannabis use and earlier age at onset (1) of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr Pharm Des
2012; 18: 5055–69.
Gage, SH, Hickman, M, Zammit, S.
Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry
2016; 79: 549–56.
Arseneault, L, Cannon, M, Poulton, R, Murray, R, Caspi, A, Moffitt, TE.
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ
2002; 325: 1212–3.
Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, et al.
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ
2005; 330: 11.
Kelley, ME, Wan, CR, Broussard, B, Crisafio, A, Cristofaro, S, Johnson, S, et al.
Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders. Schizophr Res
2016; 17: 62–7.
Bechtold, J, Hipwell, A, Lewis, DA, Loeber, R, Pardini, D.
Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms. Am J Psychiatry
2016; 173: 781–9.
Auther, AM, Cadenhead, KS, Carrion, RE, Addington, J, Bearden, CE, Cannon, TD, et al.
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand
2015; 132: 60–8.
Miettunen, J, Tormanen, S, Murray, GK, Jones, PB, Maki, P, Ebeling, H, et al.
Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry
2008; 192: 470–1.
Jarvelin, MR, Hartikainen-Sorri, AL, Rantakallio, P.
Labour induction policy in hospitals of different levels of specialisation. Br J Obstet Gynaecol
1993; 100: 310–5.
Heinimaa, M, Salokangas, RK, Ristkari, T, Plathin, M, Huttunen, J, Ilonen, T, et al.
PROD-screen--a screen for prodromal symptoms of psychosis. Int J Methods Psychiatr Res
2003; 12: 92–104.
Filatova, S, Marttila, R, Koivumaa-Honkanen, H, Nordstrom, T, Veijola, J, Maki, P, et al.
A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986. Epidemiol Psychiatr Sci
2016; 28: 1–11.
Power, RA, Verweij, KJ, Zuhair, M, Montgomery, GW, Henders, AK, Heath, AC, et al.
Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry
2014; 19: 1201–4.
Nesvag, R, Reichborn-Kjennerud, T, Gillespie, NA, Knudsen, GP, Bramness, JG, Kendler, KS, et al.
Genetic and environmental contributions to the association between cannabis use and psychotic-like experiences in young adult twins. Schizophr Bull
2017; 43: 644–653.
Yung, AR, Nelson, B, Baker, K, Buckby, JA, Baksheev, G, Cosgrave, EM.
Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry
2009; 43: 118–28.
Granö, N, Karjalainen, M, Itkonen, A, Anto, J, Edlund, V, Heinimaa, M, et al.
Differential results between self-report and interview-based ratings of risk symptoms of psychosis. Early Interv Psychiatry
2011; 5: 309–14.
Horwood, J, Salvi, G, Thomas, K, Duffy, L, Gunnell, D, Hollis, C, et al.
IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry
2008; 193: 185–91.
Bagot, KS, Milin, R, Kaminer, Y.
Adolescent initiation of cannabis use and early-onset psychosis. Subst Abus
2015; 36: 524–533.
Radhakrishnan, R, Wilkinson, ST, D'Souza, DC.
Gone to pot - a review of the association between cannabis and psychosis. Front Psychiatry
2014; 5: 54.
Sherva, R, Wang, Q, Kranzler, H, Zhao, H, Koesterer, R, Herman, A, et al.
Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry
2016; 73: 472–80.
Gage, SH, Hickman, M, Heron, J, Munafo, MR, Lewis, G, Macleod, J, et al.
Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med
2014; 44: 3435–44.
Thanki, D, Matias, J, Griffiths, P, Noor, A, Olszewski, D, Simon, R, et al.
Prevalence of Daily Cannabis Use in the European Union and Norway. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2012.
Di Forti, M, Sallis, H, Allegri, F, Trotta, A, Ferraro, L, Stilo, SA, et al.
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull
2014; 40: 1509–17.
Murray, RM, Quigley, H, Quattrrone, D, Englund, A, Di Forti, M.
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry
2016; 15: 195–204.